chr16-57413978-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002987.3(CCL17):c.46G>A(p.Ala16Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,611,572 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002987.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCL17 | NM_002987.3 | c.46G>A | p.Ala16Thr | missense_variant | 2/4 | ENST00000219244.9 | |
CCL17 | XM_017023530.2 | c.133G>A | p.Ala45Thr | missense_variant | 4/6 | ||
CCL17 | XM_011523256.3 | c.130G>A | p.Ala44Thr | missense_variant | 4/6 | ||
CCL17 | XM_047434448.1 | c.46G>A | p.Ala16Thr | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCL17 | ENST00000219244.9 | c.46G>A | p.Ala16Thr | missense_variant | 2/4 | 1 | NM_002987.3 | P1 | |
CCL17 | ENST00000616880.1 | c.46G>A | p.Ala16Thr | missense_variant | 1/3 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000102 AC: 25AN: 245042Hom.: 0 AF XY: 0.000136 AC XY: 18AN XY: 132564
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1459456Hom.: 1 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 725706
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.46G>A (p.A16T) alteration is located in exon 2 (coding exon 1) of the CCL17 gene. This alteration results from a G to A substitution at nucleotide position 46, causing the alanine (A) at amino acid position 16 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at